AYTU BIOPHARMA, INC Repayments of Related Party Debt
AYTU BIOPHARMA, INC (AYTU) reported Repayments of Related Party Debt of $13.00 thousand for the 111-month period ending 2014-05-31, per its 10-Q filed 2014-07-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2014-11-26
- AYTU BIOPHARMA, INC repayments of related party debt for the quarter ending 2014-05-31 was $0.00.
- AYTU BIOPHARMA, INC repayments of related party debt for the quarter ending 2014-02-28 was $0.00.
- AYTU BIOPHARMA, INC repayments of related party debt for the quarter ending 2013-11-30 was $0.00.
- AYTU BIOPHARMA, INC repayments of related party debt for the quarter ending 2013-08-31 was $0.00.
- AYTU BIOPHARMA, INC repayments of related party debt for fiscal 2012 was $1.00K, a 91.67% decline from fiscal 2011.
- AYTU BIOPHARMA, INC repayments of related party debt for fiscal 2011 was $12.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 3 month as first filed | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 81 month | Repayments of Related Party Debt 84 month | Repayments of Related Party Debt 87 month | Repayments of Related Party Debt 90 month | Repayments of Related Party Debt 93 month | Repayments of Related Party Debt 96 month | Repayments of Related Party Debt 99 month | Repayments of Related Party Debt 102 month | Repayments of Related Party Debt 105 month | Repayments of Related Party Debt 108 month | Repayments of Related Party Debt 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-05-31 | $0.00 derived: 10-Q 111 month − 10-Q 108 month · filed 2014-07-10 | $0.00 derived: sum of 2 quarters · filed 2014-07-10 | $0.00 derived: sum of 3 quarters · filed 2014-07-10 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-Q · filed 2014-07-10 | |||||||||||
| 2014-02-28 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-Q · filed 2014-04-11 | |||||||||||
| 2013-11-30 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2014-01-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-Q · filed 2014-01-10 | |||||||||||
| 2013-08-31 | $0.00 derived: 10-K 102 month − 10-Q 99 month · filed 2014-11-26 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-K · filed 2014-11-26 | |||||||||||
| 2013-05-31 | $0.00 derived: 10-Q 99 month − 10-Q 96 month · filed 2013-06-28 | $0.00 derived: sum of 2 quarters · filed 2013-06-28 | $0.00 derived: sum of 3 quarters · filed 2013-06-28 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-Q · filed 2013-06-28 | |||||||||||
| 2013-02-28 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2013-04-15 | $0.00 derived: sum of 2 quarters · filed 2013-04-15 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-Q · filed 2013-04-15 | |||||||||||
| 2012-11-30 | $0.00 derived: 10-Q 93 month − 10-K 90 month · filed 2013-01-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $13.00K 10-Q · filed 2013-01-14 | |||||||||||
| 2012-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $1.00K 10-K · filed 2014-11-26 | $13.00K 10-K · filed 2012-11-29 | |||||||||||
| 2012-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | $0.00 derived: sum of 2 quarters · filed 2013-06-28 | $1.00K 10-Q · filed 2013-06-28 | $11.00K derived: sum of 4 quarters · filed 2013-06-28 | $13.00K 10-Q · filed 2012-06-26 | |||||||||||
| 2012-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | $1.00K 10-Q · filed 2013-04-15 | $11.00K derived: sum of 3 quarters · filed 2013-04-15 | $13.00K 10-Q · filed 2012-04-12 | ||||||||||||
| 2011-11-30 | $1.00K 10-Q · filed 2013-01-14 | -$1.00K 10-Q · filed 2011-12-23 | $11.00K derived: sum of 2 quarters · filed 2013-01-14 | -$13.00K 10-Q · filed 2011-12-23 | ||||||||||||
| 2011-08-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | $12.00K 10-K · filed 2012-11-29 | ||||||||||||||
| 2011-05-31 | $2.00K 10-Q · filed 2012-06-26 | |||||||||||||||
| 2010-11-30 | $0.00 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |